WHO: Steroids Boost Survival of Preterm Babies in Low-Resource Settings, New Study Finds
October 24, 2020
October 24, 2020
GENEVA, Switzerland, Oct. 24 -- The United Nations World Health Organization issued the following news release:
The results of a new clinical trial, published today in the New England Journal of Medicine, show that dexamethasone--a glucocorticoid used to treat many conditions, including rheumatic problems and severe COVID-19-- can boost survival of premature babies when given to pregnant women at risk of preterm birth in low-resource settings.
The WHO ACTION-I trial res . . .
The results of a new clinical trial, published today in the New England Journal of Medicine, show that dexamethasone--a glucocorticoid used to treat many conditions, including rheumatic problems and severe COVID-19-- can boost survival of premature babies when given to pregnant women at risk of preterm birth in low-resource settings.
The WHO ACTION-I trial res . . .